We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Treatment Beyond Progression: Is It Moving from Belief to Evidence?
- Authors
YERUSHALMI, RINAT; GELMON, KAREN
- Abstract
The article looks at a study on oncologists' normal clinical practice of either continuing the treatment beyond progression or stopping it with cytotoxic therapy. It notes that the trial includes the duration of efficacy, treatment and cardiac safety. Moreover, the trial demonstrates may be benefit in continuing trastuzumab past progression.
- Subjects
BREAST tumors; ONCOGENES; DECISION making in clinical medicine; TRASTUZUMAB; TREATMENT duration; DRUG administration; DRUG dosage; PATHOLOGICAL physiology; DRUG therapy
- Publication
Oncologist, 2010, Vol 15, Issue 8, p796
- ISSN
1083-7159
- Publication type
Article
- DOI
10.1634/theoncologist.2010-0137